The Oncology CRO for Biotech, Powered by Technology

Delivering faster, better, cheaper oncology trial results for biotech sponsors

Our Oncology CRO Executive Team

Our Oncology CRO team's expertise spans across indications with prior experience at both large and small CROs

Our experienced CRO executive team works closely with our expert site operations team to continuously review execution strategies, closely monitor patient recruitment efforts, and mitigate key study risks for oncology clinical trials.

Powered By Our Connected Technology Platform

The Vial Technology Platform leverages connected systems and intuitive design to run global trials efficiently at scale

A diagram of an oncology healthcare technology platform.
A diagram of the oncology technology platform.

Vial’s modern technology platform brings clinical trials out of the paper stone age, allowing for streamlined processes inside one end-to-end system.

no-nonsense pricing

Vial offers sponsors fixed-pricing agreements with no change orders — ever.

A line icon of a dollar sign and a price tag representing the cost of oncology services provided by a Contract Research Organization (CRO).

Flat-rate pricing

A fixed-fee pricing model guarantees a set budget for the entirety of a project, regardless of the time and expense that accrues.

Two arrows pointing in different directions, representing conflicting perspectives.

Zero change orders

Thorough planning, an experienced team, and our next-gen technology platform allow us to proactively prepare for and avert common errors or delays.

An oncology icon with gears and a warning sign.

Risk-share on commitments

We focus on delivering results that matter, and our risk share on commitments approach underscores our dedication to your trial's success.

Fast Start-up and Consolidated Site Activation

Vial’s Site Startup Platform enables sites to seamlessly onboard to our trials

The Result: Self-service onboarding eliminating administrative burden and increasing progress transparency.

Scientific Advisory Board

Experience across Immuno-Oncology

Vial CRO is supported by a team of Scientific Advisors who review and provide input on the strategy and direction of the CRO in order to build the infrastructure to advance research.

Bladder Cancer Director at the Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School
Professor of Medicine and Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah
CEO at Urology Cancer Center and XCancer Research
Director of Summit Cancer Centers, Medical Oncologist
VP, Early Stage Development at Seagen
Professor of Medicine, Professor of Surgery, and Professor of Molecular and Medical Pharmacology at the University of California Los Angeles
Medical Director for Lean and Quality Improvement, Chair of the Lymphoma/Myeloma Disease Working Group, and Associate Professor at the University of Kansas
Professor of Medicine and the Director of the Lung Cancer Medical Oncology Program at the Cleveland Clinic Taussig Cancer Institute
Genitourinary Medical Oncology Professor and Physician at The University of Texas MD Anderson Cancer Center, Houston, TX
Chief of Clinical Trials at Vanderbilt University

Discover insights to help you run trials faster and more efficiently.

Articles

Patient Recruitment in 2023: What Works and What Doesn’t in Clinical Trial Enrollment

Events / January 8-11, 2024 / San Francisco, CA

Vial will be at the 42nd Annual J.P. Morgan Healthcare Conference

Whitepapers

A Closer Look at Value-Based Healthcare in Oncology

Podcast

First in Human Episode #44 featuring Max Darnell

Articles

AI-Designed Drugs vs. Traditional Drug Discovery: Pros and Cons

Podcast

First in Human Episode #38 featuring Stephen Doyle

Advancing Cancer Care

Despite significant progress in cancer research, many patients still face limited treatment options.

Clinical trials are essential for developing new cancer treatments and advancing care for patients. Vial offers oncology sponsors solutions to support their research, including optimized study design, innovative patient recruitment strategies, and advanced data analytics techniques. By leveraging Vial, sponsors conducting oncology clinical trials can accelerate getting innovative therapies to the market, leading to better patient outcomes and contributing to the global effort to cure cancer.

Two female scientists in lab coats observing an object in a laboratory setting.
Two female scientists in lab coats observing an object in a laboratory setting.

Connect with us.

Interested in receiving a proposal from Vial? Leave us a message and some of your contact info and we’ll be in touch with you shortly.

Name(Required)
By submitting, you are agreeing to our terms and privacy policy
This field is for validation purposes and should be left unchanged.